4
Changes in Ownership
Opus Genetics, Inc. Filed Acc 0002042266-26-000002
Director sold 556,000 shares at $4.96 ($2,755,981)
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Foundation Fighting Blindness Retinal Degeneration Fund Director | 2026-09-30 | Sale | −556,000 | $4.96 | $2,755,981 | 3,236,171 | D: show line 1 in the form |
| Open-market sales · 556,000 sh · avg $4.96 · $2,755,981 | |||||||
Loading xslF345X06/primary_doc.xml…